Whalesbook
A sharp market correction, which saw investor wealth fall by ₹9 lakh crore, has created challenging conditions for equities. However, this downturn has also opened doors for opportunistic investors. Domestic brokerage Motilal Oswal has identified five stocks across the healthcare, technology, logistics, and financial services sectors that it believes offer significant upside potential, with some targets suggesting returns of up to 27%. The brokerage's strategy focuses on companies with clear growth drivers that can perform well despite market volatility.
Fortis Healthcare: Expansion Drives Growth
Motilal Oswal has initiated coverage on Fortis Healthcare with a 'Buy' rating and a target price of ₹1,100, indicating a potential 19% upside. The brokerage forecasts annual profit growth of 22% for the company between FY26 and FY28. Growth is expected to come from increased patient volumes, strategic bed additions, measured price adjustments, and continued expansion of its diagnostics business. A valuation method assessing its hospital and diagnostics operations separately underpins this positive outlook. The Indian hospital industry itself has received a 'Positive' outlook from ICRA, expecting sustained operating performance in FY2026 due to strong occupancy rates, expanding insurance penetration, and a rise in non-communicable diseases. Fortis Healthcare, with a current market capitalization of approximately ₹69,939 crore, faces competition from players like Apollo Hospitals and Max Healthcare, but its capacity expansion and focus on higher-acuity procedures are seen as key differentiators. Its current TTM P/E ratio is around 427.55.
Tech Picks: Infosys and L&T Technology Services
In the IT sector, Motilal Oswal maintains a 'Buy' rating on Infosys with a target of ₹1,450, suggesting a 17% potential upside. While stable margins are anticipated, the report flags growth challenges stemming from Artificial Intelligence (AI) potentially compressing existing business volumes and creating pricing pressures. Nevertheless, Infosys's established strength in digital transformation and AI-led services is expected to drive gradual recovery. Competitors such as Accenture, Tata Consultancy Services (TCS), and Wipro are formidable, but Infosys's execution capabilities remain a key advantage.
For L&T Technology Services (LTTS), Motilal Oswal has reiterated its 'Buy' rating with a target price of ₹5,400, implying a 19% upside. The firm highlights strong revenue growth projections for FY26 (9.6%) and anticipates accelerating growth for Q1 FY27. The company's robust deal wins and a healthy pipeline are cited as key drivers of medium-term visibility, with prior productivity challenges for key accounts largely resolved. LTTS, with a market capitalization around ₹36,685 crore, operates in a competitive IT services market. Its TTM P/E is approximately 30.83.
Delhivery: Poised for Logistics Gains
Delhivery is a top pick in the logistics sector, carrying a 'Buy' rating and a target of ₹570, representing a significant 27% upside potential. Motilal Oswal forecasts the Express segment revenue to grow at a 16% CAGR from FY25 to FY28. The brokerage anticipates substantial operating profit (EBITDA) and net profit (PAT) expansion, with projected annual growth rates of approximately 44% and 52% respectively over the same period. Delhivery achieved its first profitable fiscal year in FY25 and leads the Indian express logistics market with an estimated 14% share, competing with players like Blue Dart and XpressBees. The Indian logistics market is projected to reach USD 362 billion by FY30, with express parcel delivery as a key driver. However, Delhivery's current valuation, with a P/E ratio around 243.47 and a low ROE of 1.52%, suggests aggressive growth expectations are already priced in, making it vulnerable to execution risks.
UTI AMC: Stable Financial Services Performance
In financial services, UTI Asset Management Company (AMC) is rated 'Buy' with a target price of ₹1,270, signaling a 23% upside potential. Motilal Oswal expects stable earnings for FY27 and FY28, noting that potential impacts from AUM declines are partially mitigated by controlled employee costs. Structural strengths such as strong retail participation, consistent systematic investment plan (SIP) inflows, and efficiency gains from digital initiatives are key support factors. UTI AMC, with a market capitalization around ₹13,310 crore and a P/E ratio of about 21.80, operates in a competitive AMC landscape alongside entities like HDFC AMC and Nippon Life India AMC. Its Assets Under Management (AUM) stood at ₹22,41,837 crore as of September 2025.
Growth Catalysts and Potential Risks
The core catalysts for these recommendations include sustained earnings growth, potential margin expansion, and favorable sector-specific demand trends. The healthcare sector benefits from structural tailwinds like an aging population and increased insurance penetration. The logistics sector is boosted by the e-commerce wave and industry consolidation. The IT sector, despite near-term AI-related pressures for some, continues to be driven by strong demand for digital transformation services. The Indian healthcare industry is valued at $610 billion by 2026, with organized players benefiting from consolidation.
However, investors should be aware of potential risks. A global demand slowdown, persistent pricing pressures in IT services, and evolving regulatory landscapes in healthcare present notable concerns. Additionally, the high valuations of some companies, particularly Delhivery and Fortis Healthcare, warrant careful consideration of execution risk and the sustainability of projected growth. Infosys faces ongoing threats from AI-driven commoditization, while LTTS's reliance on large deals makes it sensitive to macro-economic shifts. UTI AMC operates in a highly competitive space where AUM performance is tied to market volatility.